USFDA concludes inspection at Zydus’ group manufacturing facility in Ahmedabad

08 Jul 2023 Evaluate

United States Food and Drug Administration (USFDA) has concluded inspection of group’s manufacturing facility of Zydus Lifesciences at SEZ-2 located at Pharmez, Ahmedabad. The manufacturing facility underwent a USFDA inspection from July 2, 2023 to July 7, 2023. The Pre-Approval Inspection (PAI) closed with nil observations.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company. 


Zydus Lifesciences Share Price

876.10 3.15 (0.36%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×